Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Glixis Therapeutics

2012 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$300K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of novel therapies for autoimmune diseases. The company focuses on glyco-engineering novel therapies for autoimmune disease.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 122 Calistoga Road 346
  • Santa Rosa, CA 95409
  • United States

+1 (818) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Glixis Therapeutics’s full profile, request a free trial.

Glixis Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 12-Jun-2014 $300K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Glixis Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0

Glixis Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Ani Oganesyan Ph.D Founder & Senior Scientist